Biotech News
Progyny, Inc. Announces Third Quarter 2025 Results
investors.progyny.com2026-05-06 14:46 EST
Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base Record $156.0 Million in Operating Cash Flow Generated over